Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of…

The Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthPhilippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of…

The Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.

View Premium plansBrowse free archive reports